Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Hao Chi"'
Autor:
Dongfeng Tan, John A. Thompson, Mehmet Altan, Kavea Panneerselvam, Hao Chi Zhang, Yinghong Wang, Anusha Shirwaikar Thomas, Petros Grivas, Rajan Amin, David Richards, Phillip Lum, Dongguang Wei
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:896-904
Background: Although immune checkpoint inhibitors (ICIs) have provided practice-changing outcomes in treating many cancers, ICI-related gastrointestinal toxicity can limit their use. Upper gastrointestinal toxicity is not common nor as well described
Autor:
Aline Charabaty, Zimu Gong, Pablo C. Okhuysen, Yuanzun Peng, Yinghong Wang, Jennifer L. McQuade, Hao Chi Zhang, Mehmet Altan, Hamzah Abu-Sbeih, Weijie Ma, Frederick B. Peng, Fangwen Zou, Anusha Shirwaikar Thomas
Publikováno v:
American Journal of Clinical Oncology. 44:402-408
Background and objective Immune-mediated diarrhea and colitis (IMDC) is a common adverse event in cancer patients receiving immune checkpoint inhibitors (ICIs). Gastrointestinal (GI) infections can co-occur with IMDC, and its impact on the course and
Autor:
Sarina Anne Piha-Paul, Weijie Ma, Hamzah Abu-Sbeih, Jianbo Wang, John A. Thompson, Amishi Yogesh Shah, Fangwen Zou, Wei Qiao, Anusha Shirwaikar Thomas, Isabella C. Glitza Oliva, Hao Chi Zhang, Yinghong Wang, Yuanzun Peng
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:700-708
Background: Immune-mediated diarrhea and colitis (IMDC) is a common immune-related adverse effect related to immune checkpoint inhibitors. We aimed to identify risk factors for chronic IMDC and its prognostic value in cancer outcomes. Methods: We ret
Publikováno v:
Physical Therapy Rehabilitation Science. 9:222-229
Publikováno v:
Clinical Endoscopy, Vol 53, Iss 2, Pp 167-175 (2020)
Clinical Endoscopy
Clinical Endoscopy
Concomitant malignant gastric outlet obstruction and biliary obstruction may occur in patients with advanced cancers affecting these anatomical regions. This scenario presents a unique challenge to the endoscopist in selecting an optimal management a
Autor:
Anam Khan, Wei Qiao, Hao Chi Zhang, Hamzah Abu-Sbeih, Shruti Khurana, Weijie Ma, David M. Richards, Wai Chin Foo, Anusha Shirwaikar Thomas, Yinghong Wang
Publikováno v:
American journal of clinical oncology. 44(8)
Background Eosinophilic colitis (EoC) is a rare form of eosinophilic gastrointestinal disease characterized by diffuse eosinophilic infiltration in the deep lamina propria of colonic mucosa. The pathophysiology is unclear, but EoC has been associated
Autor:
Jianqing Ma, Shaoping Ha, Hao Chi, Zhongqi Xue, Shunyu Piao, Wen-Juan Zhuang, Manyun Xu, Shaolin Wang, Wen Zhang, Juan Hao
Publikováno v:
International Journal of Ophthalmology, Vol 12, Iss 8, Pp 1317-1322 (2019)
AIM: To investigate whether the gene variants in MYOC and ABCA1 are associated with primary angle-closure glaucoma (PACG) and anterior chamber depth (ACD) and axial length (AL) in samples from northern China. METHODS: The present case-control associa
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-8 (2019)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Background Immune checkpoint inhibitors (ICPIs), used to treat different advanced malignancies, are associated with a wide range of immune-related adverse reactions (irAEs) that deserve close monitoring of patients. Gastrointestinal reactions and hep
Autor:
Anusha Shirwaikar Thomas, Jennifer Wang, Jennifer L. McQuade, Fangwen Zou, Hao Chi Zhang, Yinghong Wang, Isabella C. Glitza, Xuemei Wang, John A. Thompson
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)
BackgroundImmune-mediated diarrhea and colitis (IMDC) is currently diagnosed and monitored by evaluating clinical symptoms. Deep remission is determined by endoscopic and histologic evaluation of the disease process. However, repeating these invasive
Autor:
John A. Thompson, Fiyinfoluwa Abraham, Jake S. Jacob, Isabella C. Glitza Oliva, Petros Grivas, Barbara E. Dutra, Anusha Shirwaikar Thomas, Yinghong Wang, Victor Garcia-Rodriguez, Hao Chi Zhang, Fangwen Zou, Weijie Ma, Kavea Panneerselvam, Mehmet Altan
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 19(12)
Background: Immune checkpoint inhibitor (ICI) therapy predisposes patients to immune-related adverse events (irAEs). Data are limited regarding the incidence, management, and outcomes of one such irAE: mucositis. In this study, we evaluated the clini